Financial Snapshot

Revenue
$36.79M
TTM
Gross Margin
83.29%
TTM
Net Earnings
-$10.87M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
113.35%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$24.47M
Q3 2024
Cash
Q3 2024
P/E
-1.524
Nov 29, 2024 EST
Free Cash Flow
-$1.700M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Revenue $39.55M $42.01M $35.99M $37.44M $34.39M $29.34M $26.32M $33.03M $900.0K $600.0K $800.0K $700.0K $51.14M $45.88M $43.54M $35.08M $28.06M $17.82M $10.69M $12.03M
YoY Change -5.85% 16.75% -3.89% 8.88% 17.19% 11.48% -20.3% 3569.51% 50.0% -25.0% 14.29% -98.63% 11.48% 5.37% 24.12% 25.02% 57.46% 66.7% -11.14%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Revenue $39.55M $42.01M $35.99M $37.44M $34.39M $29.34M $26.32M $33.03M $900.0K $600.0K $800.0K $700.0K $51.14M $45.88M $43.54M $35.08M $28.06M $17.82M $10.69M $12.03M
Cost Of Revenue $6.067M $9.119M $8.811M $8.653M $7.421M $6.017M $5.418M $5.959M $4.968M $5.053M $5.439M $5.046M $5.363M $3.587M $4.140M $3.050M $2.670M $2.400M $530.0K $820.0K
Gross Profit $33.49M $32.89M $27.17M $28.79M $26.97M $23.33M $20.90M $27.07M -$4.068M -$4.453M -$4.639M -$4.346M $45.78M $42.29M $39.40M $32.03M $25.39M $15.42M $10.16M $11.21M
Gross Profit Margin 84.66% 78.29% 75.51% 76.89% 78.42% 79.5% 79.42% 81.96% -452.02% -742.19% -579.93% -620.88% 89.51% 92.18% 90.49% 91.31% 90.48% 86.53% 95.04% 93.18%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Selling, General & Admin $28.93M $26.84M $24.80M $24.96M $25.25M $24.16M $23.10M $23.12M $21.60M $23.30M $23.88M $29.39M $30.25M $30.77M $27.84M $19.53M $14.19M $10.35M $8.240M $9.160M
YoY Change 7.77% 8.25% -0.67% -1.15% 4.54% 4.57% -0.07% 7.0% -7.3% -2.4% -18.74% -2.85% -1.71% 10.54% 42.55% 37.63% 37.1% 25.61% -10.04%
% of Gross Profit 86.38% 81.6% 91.25% 86.71% 93.64% 103.55% 110.5% 85.4% 66.07% 72.77% 70.66% 60.97% 55.89% 67.12% 81.1% 81.71%
Research & Development $5.834M $6.689M $5.684M $5.774M $6.868M $7.576M $4.248M $3.191M $3.848M $3.389M $5.616M $5.095M $5.028M $4.327M $4.990M $4.430M $3.690M $2.230M $1.160M $750.0K
YoY Change -12.78% 17.67% -1.55% -15.94% -9.34% 78.36% 33.13% -17.07% 13.52% -39.64% 10.21% 1.33% 16.19% -13.28% 12.64% 20.05% 65.47% 92.24% 54.67%
% of Gross Profit 17.42% 20.34% 20.92% 20.06% 25.47% 32.48% 20.32% 11.79% 10.98% 10.23% 12.66% 13.83% 14.53% 14.46% 11.42% 6.69%
Depreciation & Amortization $4.936M $5.328M $4.606M $4.749M $4.404M $2.983M $2.648M $2.397M $2.247M $1.990M $1.302M $901.6K $1.040M $978.4K $820.0K $790.0K $760.0K $590.0K $50.00K $40.00K
YoY Change -7.36% 15.67% -2.99% 7.82% 47.66% 12.65% 10.47% 6.68% 12.93% 52.83% 44.38% -13.34% 6.34% 19.32% 3.8% 3.95% 28.81% 1080.0% 25.0%
% of Gross Profit 14.74% 16.2% 16.95% 16.49% 16.33% 12.79% 12.67% 8.86% 2.27% 2.31% 2.08% 2.47% 2.99% 3.83% 0.49% 0.36%
Operating Expenses $39.70M $33.53M $30.48M $30.74M $32.12M $31.73M $27.35M $26.31M $25.45M $26.69M $29.49M $34.48M $35.28M $35.10M $33.62M $24.74M $18.67M $13.19M $9.410M $9.640M
YoY Change 18.39% 10.01% -0.83% -4.31% 1.23% 16.03% 3.96% 3.36% -4.66% -9.49% -14.46% -2.25% 0.5% 4.41% 35.89% 32.51% 41.55% 40.17% -2.39%
Operating Profit -$6.211M -$5.705M -$7.677M -$6.382M -$9.288M -$11.17M -$8.879M -$1.433M $1.112M $3.559M -$3.801M $8.818M $9.849M $6.502M $5.780M $7.290M $6.720M $2.230M $750.0K $1.570M
YoY Change 8.87% -25.69% 20.31% -31.29% -16.87% 25.83% 519.58% -228.92% -68.76% -193.62% -143.11% -10.47% 51.49% 12.49% -20.71% 8.48% 201.35% 197.33% -52.23%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Interest Expense -$381.0K $586.0K $98.03K $263.6K $246.2K $195.8K $92.90K $106.4K $73.86K $67.07K $103.4K $71.99K $353.5K $1.424M -$690.0K $30.00K -$260.0K -$510.0K $30.00K -$1.010M
YoY Change -165.02% 497.76% -62.81% 7.08% 25.7% 110.81% -12.68% 44.05% 10.11% -35.15% 43.67% -79.64% -75.17% -306.31% -2400.0% -111.54% -49.02% -1800.0% -102.97%
% of Operating Profit 6.64% 1.88% 0.82% 3.59% 21.89% -11.94% 0.41% -3.87% -22.87% 4.0% -64.33%
Other Income/Expense, Net $3.651M $611.3K $2.187M $0.00 $0.00 $0.00 -$10.00K $0.00
YoY Change 497.17% -72.05% -100.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Pretax Income -$6.285M -$5.581M -$5.562M -$6.570M -$9.291M -$10.80M -$8.673M -$1.335M $1.247M $3.743M -$3.674M $9.051M $9.707M $5.278M $5.080M $7.310M $6.470M $1.710M $770.0K $560.0K
YoY Change 12.61% 0.34% -15.34% -29.29% -14.01% 24.58% 549.73% -207.05% -66.69% -201.87% -140.6% -6.76% 83.89% 3.91% -30.51% 12.98% 278.36% 122.08% 37.5%
Income Tax $45.77K $68.85K $34.89K $55.90K -$79.32K $16.64K $4.175M -$330.9K $575.8K $1.381M -$1.523M $3.245M $4.080M $2.851M $2.020M $2.540M $2.420M -$2.700M -$1.180M $0.00
% Of Pretax Income 46.18% 36.89% 35.85% 42.03% 54.02% 39.76% 34.75% 37.4% -157.89% -153.25% 0.0%
Net Earnings -$6.279M -$5.570M -$3.508M -$3.339M -$3.538M -$6.963M -$7.979M -$944.7K $731.4K $2.424M -$2.105M $5.842M $5.658M $2.457M $3.090M $4.770M $4.040M $4.410M $1.950M $560.0K
YoY Change 12.73% 58.81% 5.04% -5.61% -49.19% -12.73% 744.58% -229.17% -69.83% -215.16% -136.02% 3.26% 130.3% -20.5% -35.22% 18.07% -8.39% 126.15% 248.21%
Net Earnings / Revenue -15.88% -13.26% -9.75% -8.92% -10.29% -23.73% -30.31% -2.86% 81.26% 403.95% -263.08% 834.64% 11.06% 5.36% 7.1% 13.6% 14.4% 24.75% 18.24% 4.66%
Basic Earnings Per Share -$0.44 -$0.38 -$0.24 -$0.22 -$0.23 -$0.45 -$0.50 -$0.06 $0.04 $0.14 -$0.11 $0.30 $0.28 $0.12
Diluted Earnings Per Share -$0.44 -$0.38 -$0.24 -$0.22 -$0.23 -$0.45 -$0.50 -$0.06 $0.04 $0.14 -$0.11 $0.30 $0.28 $0.12 $169.5K $288.4K $243.7K $268.1K $119.6K $36.18K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Cash & Short-Term Investments $18.32M $19.76M $27.04M $24.80M $28.20M $36.20M $50.10M $50.10M $52.80M $54.70M $54.90M $71.00M $70.60M $65.90M $78.70M $11.80M $10.80M $6.300M $5.500M
YoY Change -7.27% -26.93% 9.04% -12.06% -22.1% -27.74% 0.0% -5.11% -3.47% -0.36% -22.68% 0.57% 7.13% -16.26% 566.95% 9.26% 71.43% 14.55%
Cash & Equivalents $18.32M $19.76M $27.04M $24.80M $28.20M $27.90M $45.40M $34.50M $38.20M $39.90M $40.90M $54.30M $70.60M $65.90M $78.70M $11.80M $10.80M $6.300M $5.500M
Short-Term Investments $0.00 $8.300M $4.700M $15.60M $14.60M $14.80M $14.00M $16.70M
Other Short-Term Assets $3.025M $3.085M $3.340M $2.200M $2.800M $3.000M $3.500M $2.700M $4.000M $5.100M $3.500M $4.000M $3.800M $2.300M $3.400M $1.000M $700.0K $600.0K $100.0K
YoY Change -1.94% -7.63% 51.82% -21.43% -6.67% -14.29% 29.63% -32.5% -21.57% 45.71% -12.5% 5.26% 65.22% -32.35% 240.0% 42.86% 16.67% 500.0%
Inventory $4.609M $9.864M $8.430M $10.60M $9.400M $12.10M $6.700M $5.400M $4.300M $5.600M $5.700M $6.200M $5.800M $7.700M $4.800M $1.800M $900.0K $700.0K $500.0K
Prepaid Expenses
Receivables $9.758M $13.16M $6.877M $12.40M $9.800M $7.800M $8.400M $7.300M $6.100M $5.500M $4.500M $6.000M $7.100M $5.100M $6.200M $3.100M $2.400M $5.100M $2.400M
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $35.71M $45.87M $45.69M $50.00M $50.20M $59.10M $68.70M $65.50M $67.10M $70.80M $68.70M $87.20M $87.30M $81.00M $93.20M $17.70M $14.80M $12.60M $8.600M
YoY Change -22.14% 0.4% -8.62% -0.4% -15.06% -13.97% 4.89% -2.38% -5.23% 3.06% -21.22% -0.11% 7.78% -13.09% 426.55% 19.59% 17.46% 46.51%
Property, Plant & Equipment $7.042M $5.502M $1.467M $2.600M $3.700M $800.0K $500.0K $500.0K $500.0K $700.0K $900.0K $1.200M $1.100M $1.200M $900.0K $400.0K $500.0K $400.0K $400.0K
YoY Change 27.99% 275.12% -43.58% -29.73% 362.5% 60.0% 0.0% 0.0% -28.57% -22.22% -25.0% 9.09% -8.33% 33.33% 125.0% -20.0% 25.0% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $15.50M $10.05M $12.47M $14.90M $18.90M $18.40M $2.600M $5.200M $3.100M $2.400M $2.600M $700.0K $100.0K $2.400M $1.700M $4.400M $4.500M $3.600M $1.200M
YoY Change 54.24% -19.41% -16.32% -21.16% 2.72% 607.69% -50.0% 67.74% 29.17% -7.69% 271.43% 600.0% -95.83% 41.18% -61.36% -2.22% 25.0% 200.0%
Total Long-Term Assets $46.06M $47.05M $38.77M $46.50M $54.30M $53.60M $24.50M $27.90M $24.80M $24.60M $18.90M $11.40M $8.200M $11.10M $10.50M $13.40M $14.10M $13.90M $1.600M
YoY Change -2.11% 21.36% -16.62% -14.36% 1.31% 118.78% -12.19% 12.5% 0.81% 30.16% 65.79% 39.02% -26.13% 5.71% -21.64% -4.96% 1.44% 768.75%
Total Assets $81.78M $92.93M $84.46M $96.50M $104.5M $112.7M $93.20M $93.40M $91.90M $95.40M $87.60M $98.60M $95.50M $92.10M $103.7M $31.10M $28.90M $26.50M $10.20M
YoY Change
Accounts Payable $14.04M $10.82M $9.641M $13.40M $11.90M $11.10M $9.000M $8.000M $2.900M $3.200M $2.000M $2.800M $1.500M $2.100M $5.600M $3.300M $1.900M $3.400M $1.000M
YoY Change 29.75% 12.22% -28.05% 12.61% 7.21% 23.33% 12.5% 175.86% -9.38% 60.0% -28.57% 86.67% -28.57% -62.5% 69.7% 73.68% -44.12% 240.0%
Accrued Expenses $1.546M $2.223M $2.329M $2.300M $3.000M $1.700M $5.300M $5.100M $4.400M $3.800M $2.600M $2.600M $1.400M $600.0K
YoY Change -30.47% -4.52% 1.25% -23.33% 76.47% 3.92% 15.91% 15.79% 46.15% 0.0% 85.71% 133.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.700M $9.100M $1.300M $3.200M $1.800M $300.0K
YoY Change -70.33% 600.0% -59.38% 77.78% 500.0%
Total Short-Term Liabilities $27.98M $28.58M $19.28M $25.70M $24.20M $27.80M $17.70M $14.80M $12.40M $13.70M $7.500M $8.100M $6.600M $9.200M $18.60M $7.600M $8.100M $8.700M $3.000M
YoY Change -2.09% 48.24% -24.98% 6.2% -12.95% 57.06% 19.59% 19.35% -9.49% 82.67% -7.41% 22.73% -28.26% -50.54% 144.74% -6.17% -6.9% 190.0%
Long-Term Debt $12.78M $16.20M $15.00M $15.00M $18.50M $20.00M $9.800M $4.100M $1.700M $0.00 $0.00 $4.400M $4.900M $4.500M $10.80M $5.600M $900.0K $3.600M $0.00
YoY Change -21.09% 8.0% 0.0% -18.92% -7.5% 104.08% 139.02% 141.18% -100.0% -10.2% 8.89% -58.33% 92.86% 522.22% -75.0%
Other Long-Term Liabilities $11.75M $12.17M $7.579M $8.900M $10.80M $9.300M $1.800M $1.400M $1.000M $900.0K $800.0K $600.0K $600.0K $600.0K $2.100M $400.0K $3.100M $3.100M $1.000M
YoY Change -3.46% 60.6% -14.84% -17.59% 16.13% 416.67% 28.57% 40.0% 11.11% 12.5% 33.33% 0.0% 0.0% -71.43% 425.0% -87.1% 0.0% 210.0%
Total Long-Term Liabilities $24.53M $28.37M $22.58M $23.90M $29.30M $29.30M $11.60M $5.500M $2.700M $900.0K $800.0K $5.000M $5.500M $5.100M $12.90M $6.000M $4.000M $6.700M $1.000M
YoY Change -13.53% 25.65% -5.53% -18.43% 0.0% 152.59% 110.91% 103.7% 200.0% 12.5% -84.0% -9.09% 7.84% -60.47% 115.0% 50.0% -40.3% 570.0%
Total Liabilities $52.17M $56.66M $41.65M $49.50M $53.40M $56.80M $29.10M $20.20M $15.00M $14.60M $8.100M $12.90M $12.60M $14.30M $31.50M $13.60M $12.20M $15.40M $3.900M
YoY Change -7.92% 36.05% -15.87% -7.3% -5.99% 95.19% 44.06% 34.67% 2.74% 80.25% -37.21% 2.38% -11.89% -54.6% 131.62% 11.48% -20.78% 294.87%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $16.57 Million

About CUMBERLAND PHARMACEUTICALS INC

Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which focuses on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The company is headquartered in Nashville, Tennessee and currently employs 91 full-time employees. The company went IPO on 2009-08-11. The firm is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever, Kristalose for oral solution, a prescription laxative, for the treatment of constipation, and Omeclamox-Pak, oral, for the treatment of Helicobacter pylori infection and related duodenal ulcer disease. Its brands also include Sancuso transdermal, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia, and Vibativ injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia.

Industry: Pharmaceutical Preparations Peers: Item 9 Labs Corp. ALIMERA SCIENCES INC COGNITION THERAPEUTICS INC Hepion Pharmaceuticals, Inc. Endexx Corp JOHNSON & JOHNSON Lipocine Inc. NVN Liquidation, Inc. Zynerba Pharmaceuticals, Inc.